PMID: 7526884Dec 1, 1994Paper

Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms

British Journal of Cancer
S AntoniottiM De Bortoli

Abstract

Mitogen-induced mammary cell growth is often accompanied by decreased levels of expression of the p185erbB-2 protein. We have previously reported that oestrogen inhibits erbB-2 mRNA and protein expression in breast cancer cells, while epidermal growth factor (EGF) treatment has been shown to decrease p185erbB-2 levels in normal mouse mammary epithelial cells. In the present work, we studied the effect of oestrogen and EGF on erbB-2 expression in oestrogen-responsive breast cancer cells. We observed that both oestrogen and EGF comparably down-regulated p185erbB-2 levels, while stimulating growth of T47D and ZR75.1 cells. Oestrogens, but not EGF, concomitantly down-regulated erbB-2 mRNA. Run-on analysis showed a reduced erbB-2 transcription rate in the presence of oestrogens. Furthermore, the transcriptional activity of a 219 bp proximal fragment of the human erbB-2 promoter was repressed by oestrogens, whereas it was enhanced by EGF. EGF stimulated both tyrosine phosphorylation and autokinase activity of p185erbB-2 down-regulates p185erbB-2 at a post-translational level. Thus, two factors converging in terms of effects on cell growth, display divergent mechanisms of regulation of erbB-2 expression.

Citations

Apr 30, 1996·Annals of the New York Academy of Sciences·M De BortoliC Dati
Jan 1, 1997·Journal of Cancer Research and Clinical Oncology·R PirinenK Syrjänen
Jul 17, 1997·International Journal of Cancer. Journal International Du Cancer·P CassoniG Bussolati
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A S KnoopC Rose
Sep 25, 2003·Breast Cancer Research and Treatment·D LüftnerUNKNOWN Takeda Adjuvant Breast Cancer Study with Leuprorelin Study Group
Apr 30, 1996·Annals of the New York Academy of Sciences·P Maggiora, M De Bortoli
Jul 8, 2003·The Journal of Pathology·Caroline J WittonJohn M S Bartlett
Oct 17, 1998·Breast Cancer Research and Treatment·B BreuerP W Brandt-Rauf
Jan 16, 2007·Current Opinion in Obstetrics & Gynecology·Gianluigi FerrettiFrancesco Cognetti
Feb 24, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Athanassios ArgirisMichael P DiGiovanna
Jan 13, 1998·Biochimica Et Biophysica Acta·K S Kolibaba, B J Druker
Jan 1, 1995·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·F E May, B R Westley

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.